Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Cheryl Larson
Vice President
Midwest Business Group on Health
Chicago, IL
Co-Leader
Vice President
Midwest Business Group on Health
Chicago, IL
Co-Leader
Authored Items
Employers Engaged in Benefit Design Innovation: Long-Term Trends in a 2015 National Survey
Cheryl Larson
,
F. Randy Vogenberg, PhD, FASHP
December 2015 Vol 8, No 9
in
Perspectives
Guiding Employer Management of Specialty Drugs
Cheryl Larson
,
F. Randy Vogenberg, PhD, FASHP
July/August 2015 Vol 8 No 5
in
Perspectives
Beyond the Cost of Biologics: Employer Survey Reveals Gap in Understanding Role of Specialty Pharmacy and Benefit Design
F. Randy Vogenberg, PhD, FASHP
,
Atheer A. Kaddis, PharmD
,
Cheryl Larson
,
Margaret Rehayem, MA
,
Larry Boress, MPA
January/February 2012, Vol 5, No 1
in
Practice Management
Last modified: January 27, 2016